Clinical Trials Directory

Trials / Completed

CompletedNCT06991374

Study on the Surgical Strategy of Corneal Endothelial Protection for Hard Nuclear Cataract Patients

Combined Burst Mode Versus Torsional Mode Phacoemulsification for Patients With Hard Nuclear Cataract: A Randomized Control Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
207 (actual)
Sponsor
Eye & ENT Hospital of Fudan University · Academic / Other
Sex
All
Age
50 Years – 95 Years
Healthy volunteers
Not accepted

Summary

In this study, we compared two types of phacoemulsification commonly used in cataract surgery to evaluate their effect on the prognosis of patients with hard nuclei. This will provide a theoretical basis for selecting a more appropriate cataract surgery modality in practice in hard-nucleus patients.

Detailed description

In this study, we randomized patients into two groups. One group was the combined mode group in burst mode and the other group was the torsional ultrasound group in continuous mode. Cumulative dissipated energy(CDE) and ultrasound time(UST) were recorded during the procedure. Changes in central cornea thickness(CCT) and endothelial cell density(ECD) of the patients were recorded postoperatively during a 3-month follow-up. Intraoperative and postoperative complications were also recorded. The above data were analyzed to compare the effect of both on postoperative corneal recovery in patients with hard nuclei.

Conditions

Interventions

TypeNameDescription
PROCEDUREcombined burst modethe combined burst mode is commonly used in cataract phacoemulsification. This study compares whether the two modes have different outcomes in hard nuclear cataract surgery.
PROCEDUREtorsional modethe toesional mode is commonly used in cataract phacoemulsification. This study compares whether the two modes have different outcomes in hard nuclear cataract surgery.

Timeline

Start date
2022-08-10
Primary completion
2024-12-25
Completion
2025-03-01
First posted
2025-05-28
Last updated
2025-05-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06991374. Inclusion in this directory is not an endorsement.